XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2022     361,900,000        
Beginning Balance at Dec. 31, 2022 $ 260 $ (692) $ 10,391 $ 159 $ (9,186) $ (2,056) $ 952
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     2,100,000        
Common shares issued under share-based compensation plans 0   $ 21 (21)      
Share-based compensation 74 74   74      
Employee withholding taxes related to share-based awards (15) (15)   (15)      
Vesting of B+L equity compensation 0 (9)   (9)     9
Net income (loss) (182) (175)     (175)   (7)
Other comprehensive income (loss) 134 154       154 (20)
Ending Balance (in shares) at Jun. 30, 2023     364,000,000.0        
Ending Balance at Jun. 30, 2023 271 (663) $ 10,412 188 (9,361) (1,902) 934
Beginning Balance (in shares) at Mar. 31, 2023     363,600,000        
Beginning Balance at Mar. 31, 2023 145 (800) $ 10,405 171 (9,387) (1,989) 945
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     400,000        
Common shares issued under share-based compensation plans 0   $ 7 (7)      
Share-based compensation 33 33   33      
Employee withholding taxes related to share-based awards (3) (3)   (3)      
Vesting of B+L equity compensation 0 (6)   (6)     6
Net income (loss) 27 26     26   1
Other comprehensive income (loss) 69 87       87 (18)
Ending Balance (in shares) at Jun. 30, 2023     364,000,000.0        
Ending Balance at Jun. 30, 2023 $ 271 (663) $ 10,412 188 (9,361) (1,902) 934
Beginning Balance (in shares) at Dec. 31, 2023 365,238,917   365,200,000        
Beginning Balance at Dec. 31, 2023 $ (82) (1,022) $ 10,423 214 (9,778) (1,881) 940
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,800,000        
Common shares issued under share-based compensation plans 0   $ 60 (60)      
Share-based compensation 69 69   69      
Employee withholding taxes related to share-based awards (18) (18)   (18)      
Vesting of B+L equity compensation 0 (24)   (24)     24
Net income (loss) (78) (54)     (54)   (24)
Other comprehensive income (loss) $ (118) (126)       (126) 8
Ending Balance (in shares) at Jun. 30, 2024 366,985,967   367,000,000.0        
Ending Balance at Jun. 30, 2024 $ (227) (1,175) $ 10,483 181 (9,832) (2,007) 948
Beginning Balance (in shares) at Mar. 31, 2024     366,700,000        
Beginning Balance at Mar. 31, 2024 (174) (1,115) $ 10,480 164 (9,842) (1,917) 941
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     300,000        
Common shares issued under share-based compensation plans 0   $ 3 (3)      
Share-based compensation 36 36   36      
Employee withholding taxes related to share-based awards (4) (4)   (4)      
Vesting of B+L equity compensation 0 (12)   (12)     12
Net income (loss) (1) 10     10   (11)
Other comprehensive income (loss) $ (84) (90)       (90) 6
Ending Balance (in shares) at Jun. 30, 2024 366,985,967   367,000,000.0        
Ending Balance at Jun. 30, 2024 $ (227) $ (1,175) $ 10,483 $ 181 $ (9,832) $ (2,007) $ 948